EGFR and non-small cell lung carcinoma: Acquired EGFR exon 20 mutations were seen in two patients, one with a T790M mutation and one with an exon 20 insertion (D770_N771insN), both of which are well-studied in NSCLC as an acquired [40] and de novo resistance mechanism to EGFR tyrosine kinase inhibitors [41], respectively.